Literature DB >> 28038808

Recurrent in-stent restenosis, certainty of its origin, uncertainty about treatment.

Davide Piraino1, Giuliana Cimino2, Dario Buccheri2, Gregory Dendramis2, Giuseppe Andolina2, Bernardo Cortese3.   

Abstract

Treatment of recurrent in-stent restenosis is a real brainteaser for the interventional cardiologist who cannot resort to the guidelines to have indications about the type of treatment to be preferred. The use of intracoronary imaging may provide insights into the underlying mechanisms of this complication and use of drug-coated balloons may be a valid alternative and especially a thoughtful treatment when the repeated and perseverant use of drug-eluting stents clearly fails. In this setting, we present a review of the literature about this interesting topic, going deep into the heart of the problem, its origin and possible treatment options.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Drug-coated balloon; Optical coherence tomography; Percutaneous coronary intervention; Recurrent in-stent restenosis

Mesh:

Year:  2016        PMID: 28038808     DOI: 10.1016/j.ijcard.2016.12.073

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

1.  Cardiovascular delivery of drugs and biotherapeutics.

Authors:  Michael Chorny; Robert J Levy; Gershon Golomb
Journal:  Drug Deliv Transl Res       Date:  2018-08       Impact factor: 4.617

2.  Association Between TG-to-HDL-C Ratio and In-Stent Stenosis Under Optical Coherence Tomography Guidance.

Authors:  Ya Li; Peng Jin; Fangjie Hou; Yujie Zhou
Journal:  J Med Syst       Date:  2018-11-20       Impact factor: 4.460

3.  A homogenized constrained mixture model of restenosis and vascular remodelling after balloon angioplasty.

Authors:  Lauranne Maes; An-Sofie Cloet; Inge Fourneau; Nele Famaey
Journal:  J R Soc Interface       Date:  2021-05-05       Impact factor: 4.118

4.  Targeting AGGF1 (angiogenic factor with G patch and FHA domains 1) for Blocking Neointimal Formation After Vascular Injury.

Authors:  Yufeng Yao; Zhenkun Hu; Jian Ye; Changqing Hu; Qixue Song; Xingwen Da; Yubin Yu; Hui Li; Chengqi Xu; Qiuyun Chen; Qing Kenneth Wang
Journal:  J Am Heart Assoc       Date:  2017-06-25       Impact factor: 5.501

5.  Comparison of the safety and efficacy of two types of drug-eluting balloons (RESTORE DEB and SeQuent® Please) in the treatment of coronary in-stent restenosis: study protocol for a randomized controlled trial (RESTORE ISR China).

Authors:  Lei Gao; Qin Qin; Shao-Liang Chen; Hui Chen; Le-Feng Wang; Ze-Ning Jin; Hui Li; Jun Zhang; Jian-An Wang; Yang Zheng; Guo-Sheng Fu; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2018-02       Impact factor: 3.327

6.  In vitro study of the inflammatory cells response to biodegradable Mg-based alloy extract.

Authors:  Liang Jin; Jing Wu; Guangyin Yuan; Tongxin Chen
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

7.  Towards non-invasive characterisation of coronary stent re-endothelialisation - An in-vitro, electrical impedance study.

Authors:  Ian Holland; Christopher McCormick; Patricia Connolly
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

8.  Drug-eluting balloons versus new generation drug-eluting stents for the management of in-stent restenosis: an updated meta-analysis of randomized studies.

Authors:  Lei Gao; Ya-Bin Wang; Jing Jing; Ming Zhang; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2019-06       Impact factor: 3.327

9.  A Biodegradable Mg-Based Alloy Inhibited the Inflammatory Response of THP-1 Cell-Derived Macrophages Through the TRPM7-PI3K-AKT1 Signaling Axis.

Authors:  Liang Jin; Chenxin Chen; Yutong Li; Feng Yuan; Ruolan Gong; Jing Wu; Hua Zhang; Bin Kang; Guangyin Yuan; Hui Zeng; Tongxin Chen
Journal:  Front Immunol       Date:  2019-12-03       Impact factor: 7.561

10.  The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease.

Authors:  Turgut Karabağ; Emіne Altuntaş; Belma Kalaycı; Bahar Şahіn; Mustafa Umut Somuncu; Mustafa Ozan Çakır
Journal:  Interv Med Appl Sci       Date:  2018-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.